Hematology A&I Teams: Structure, Branding & Innovation

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Maximizing the Impact of Hematology Analytics & Insights Teams: Delivering Value through Structure, Branding, and Innovation”

STUDY OVERVIEW

In a field as dynamic as hematology, where breakthroughs and competitive shifts occur with increasing speed, companies must ensure their Analytics & Insights (A&I) teams are not only embedded across the value chain but also driving high-value decisions. They are being called upon to shape enterprise strategy and demonstrate business-critical value. For senior leaders, the way these teams are structured and positioned within the organization determines whether insights become strategic levers or remain underutilized assets.

This study by Best Practices, LLC examines how leading companies transform their Hematology A&I teams into trusted partners that drive impact across scientific, medical, and commercial functions. It highlights the organizational models, branding strategies, and innovation practices that allow A&I leaders to build internal credibility, foster alignment, and ultimately convert analytics into enterprise-wide influence.

KEY TOPICS

Core responsibilities and clients supported by Hematology A&I teams
Valuable strategic practices, skill sets, and expertise areas
Internal branding programs
Top A&I obstacles, mistakes and lessons
Innovative pilots, design thinking and patient engagement

KEY METRICS

Time investment by Hematology A&I groups across key internal functions
Role played by Hematology Analytics & Insights teams in fulfilling the listed organizational capabilities
Strategic initiatives used by Hematology A&I teams to enhance stakeholder impact
Soft skills and prior experiences professional backgrounds valued in Hematology A&I roles
Most critical technical competencies shaping the future of hematology A&I professionals
Primary barriers that may limit long-term effectiveness of Hematology Analytics & Insights functions
Internal branding campaign rollout to shape perception of the Hematology A&I function
Key organizational objectives driving internal branding campaigns within Hematology Analytics & Insights functions
Vendor involvement in building or supporting internal branding efforts
Application of design thinking to accelerate innovation and performance outcomes
Direct-to-patient insight-gathering approaches to inform real-world hematology strategy
Disease areas where patient engagement initiatives have demonstrated measurable impact (primary care, specialty, and rare diseases)
Disease areas showing patient impact when engagement is segmented by drug type and route

SAMPLE KEY FINDINGS

Highest Strategic Value for A&I Teams May Come Through Less-Routine Activities: 85-95% of benchmarked hematology A&I teams routinely provide insights-based recommendations, interpret insights, and leverage experience to be effective advisors. Best-in-class teams may be bolder, recommending specific business action with implementation plans, focusing on business risks or incubating genuine innovation, thereby providing evidence-based success stories for other groups (such as Medical Affairs) to demonstrate their value internally. A&I teams in smaller organizations more routinely execute these tactics.

METHODOLOGY

Best Practices, LLC engaged 12 Analytics & Insights leaders across 12 leading biopharma organizations with a focus on the hematology segment. This study includes segmentation by company size (mid vs. large pharma) and features deep-dive interviews for added qualitative insights. Notably, over 33% of benchmark participants serve at the director-level or above.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Consulting; Research; Health Care; Biopharmaceutical; Clinical Research; Laboratories

Companies Profiled:
AstraZeneca; Bayer; Biotest AG; Decode Consulting; Janssen; Lonza Inc.; MEDiSTRAVA; Momenta; Novartis; Sanofi; Takeda Pharmaceuticals; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Maximizing the Impact of Hematology Analytics & Insights Teams: Delivering Value through Structure, Branding, and Innovation

ID: 5889

Features:

Pages/Slides: 46

Published: 2025

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6109032676987F6C900258CBD001B2126
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-maximizing-impact-hematology-analytics-insights-teams-delivering-value-structure-branding-innovation?opendocument
18
19opendocument
2018.97.9.174
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB